Regulation of angiogenesis-related prostaglandin F2alpha-induced genes in the bovine corpus luteum

Biology of Reproduction

Volumn 86, Issue 3, 2012, Pages

  Zalman, Yulia ^a   Klipper, Eyal ^a   Farberov, Svetlana ^a   Mondal, Mohan ^b,c   Wee, Gabbine ^c   Folger, Joseph K ^c   Smith, George W ^c   Meidan, Rina ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b National Research Centre on Mithun India   (India)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Corpus luteum; Gonadal function; Luteolysis; Prostaglandins

Indexed keywords

CD36 ANTIGEN; MESSENGER RNA; PENTRAXIN 3; PROSTAGLANDIN F2 ALPHA; THROMBOSPONDIN 1; THROMBOSPONDIN 2; VASCULOTROPIN; C REACTIVE PROTEIN; FIBROBLAST GROWTH FACTOR 2; SERUM AMYLOID P; THROMBOSPONDIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS LUTEUM; COW; ENDOTHELIUM CELL; ESTRUS CYCLE; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; IN VITRO STUDY; IN VIVO STUDY; LUTEAL CELL; LUTEAL PHASE; LUTEOLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROIDOGENESIS; TILTING; UPREGULATION; ANIMAL; ANIMAL MODEL; CATTLE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY;

BOVINAE;

ANIMALS; C-REACTIVE PROTEIN; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CORPUS LUTEUM; DINOPROST; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; LUTEAL PHASE; LUTEOLYSIS; MODELS, ANIMAL; NEOVASCULARIZATION, PHYSIOLOGIC; SERUM AMYLOID P-COMPONENT; THROMBOSPONDIN 1; THROMBOSPONDINS;

EID: 84860631996     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.095067     Document Type: Article

References (60)

1. Schams D, Berisha B. Regulation of corpus luteum function in cattle-an overview. Reprod Domest Anim 2004; 39:241-251.
2. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000; 80:1-29.
3. Schramm W, Bovaird L, Glew ME, Schramm G, McCracken JA. Corpus luteum regression induced by ultra-low pulses of prostaglandin F2 alpha. Prostaglandins 1983; 26:347-364.
4. McCracken JA, Einer-Jensen N, Fried J. Prostaglandin F2 alpha and its 13-dehydro analogs: comparative luteolytic effects in vivo. Adv Exp Med Biol 1979; 112:577-601.
5. Meidan R, Milvae RA, Weiss S, Levy N, Friedman A. Intraovarian regulation of luteolysis. J Reprod Fertil Suppl 1999; 54:217-228.
6. Pursley JR, Mee MO, Wiltbank MC. Synchronization of ovulation in dairy cows using PGF2alpha and GnRH. Theriogenology 1995; 44:915-923.
7. Levy N, Kobayashi S, Roth Z, Wolfenson D, Miyamoto A, Meidan R. Administration of prostaglandin F(2 alpha) during the early bovine luteal phase does not alter the expression of ET-1 and of its type A receptor: a possible cause for corpus luteum refractoriness. Biol Reprod 2000;63:377-382.
8. Wiltbank MC, Shiao TF, Bergfelt DR, Ginther OJ. Prostaglandin F2 alpha receptors in the early bovine corpus luteum. Biol Reprod 1995; 52:74-78.
9. Thatcher WW, Bilby TR, Bartolome JA, Silvestre F, Staples CR, Santos JE. Strategies for improving fertility in the modern dairy cow. Theriogenology 2006; 65:30-44.
10. Mondal M, Schilling B, Folger J, Steibel JP, Buchnick H, Zalman Y, Ireland JJ, Meidan R, Smith GW. Deciphering the luteal transcriptome: potential mechanisms mediating stage-specific luteolytic response of the corpus luteum to prostaglandin Falpha. Physiol Genomics 2011; 43:447-456.
11. Levy N, Gordin M, Smith MF, Bolden-Tiller OU, Meidan R. Hormonal regulation and cell-specific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells. Biol Reprod 2003; 68:1361-1368.
12. Choudhary E, Sen A, Inskeep EK, Flores JA. Developmental sensitivity of the bovine corpus luteum to prostaglandin F2alpha (PGF2alpha) and endothelin-1 (ET-1): is ET-1 a mediator of the luteolytic actions of PGF2alpha or a tonic inhibitor of progesterone secretion? Biol Reprod 2005; 72:633-642.
13. Fields MJ, Fields PA. Morphological characteristics of the bovine corpus luteum during the estrous cycle and pregnancy. Theriogenology 1996;45:1295-1325.
14. Aflalo L, Meidan R. The hormonal regulation of cholesterol side-chain cleavage cytochrome P450, adrenodoxin, and their messenger ribonucleic acid expression in bovine small-like and large-like luteal cells: relationship with progesterone production. Endocrinology 1993; 132:410-416.
15. Meidan R, Girsh E, Blum O, Aberdam E. In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics. Biol Reprod 1990; 43:913-921.
16. Spanel-Borowski K, van der Bosch J. Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM). Cell Tissue Res 1990; 261:35-47.
17. Klipper E, Levit A, Mastich Y, Berisha B, Schams D, Meidan R. Induction of endothelin-2 expression by luteinizing hormone and hypoxia: possible role in bovine corpus luteum formation. Endocrinology 2010; 151:1914-1922.
18. Klipper E, Tatz E, Kisliouk T, Vlodavsky I, Moallem U, Schams D, Lavon Y, Wolfenson D, Meidan R. Induction of heparanase in bovine granulosa cells by luteinizing hormone: possible role during the ovulatory process. Endocrinology 2009; 150:413-421.
19. Klipper E, Gilboa T, Levy N, Kisliouk T, Spanel-Borowski K, Meidan R. Characterization of endothelin-1 and nitric oxide generating systems in corpus luteum-derived endothelial cells. Reproduction 2004; 128:463-473.
20. Acosta TJ, Yoshioka S, Komiyama J, Lee SH, Grazul-Bilska AT, Skarzynski DJ, Okuda K. Effects of storage and passage of bovine luteal endothelial cells on endothelin-1 and prostaglandin F2alpha production. J Reprod Dev 2007; 53:473-480.
21. Colombo G, Margosio B, Ragona L, Neves M, Bonifacio S, Annis DS, Stravalaci M, Tomaselli S, Giavazzi R, Rusnati M, Presta M, Zetta L, et al. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds. J Biol Chem 2010; 285:8733-8742.
22. Berisha B, Meyer HH, Schams D. Effect of prostaglandin F2 alpha on local luteotropic and angiogenic factors during induced functional luteolysis in the bovine corpus luteum. Biol Reprod 2010; 82:940-947.
23. Tanaka J, Acosta TJ, Berisha B, Tetsuka M, Matsui M, Kobayashi S, Schams D, Miyamoto A. Relative changes in mRNA expression of angiopoietins and receptors tie in bovine corpus luteum during estrous cycle and prostaglandin F2alpha-induced luteolysis: a possible mechanism for the initiation of luteal regression. J Reprod Dev 2004; 50:619-626.
24. Shirasuna K, Asaoka H, Acosta TJ, Wijayagunawardane MP, Ohtani M, Hayashi M, Matsui M, Miyamoto A. Real-time relationships in intraluteal release among prostaglandin F2alpha, endothelin-1, and angiotensin II during spontaneous luteolysis in the cow. Biol Reprod 2004; 71:1706-1711.
25. Girsh E, Milvae RA, Wang W, Meidan R. Effect of endothelin-1 on bovine luteal cell function: role in prostaglandin F2alpha-induced antisteroidogenic action. Endocrinology 1996; 137:1306-1312.
26. Doerr MD, Goravanahally MP, Rhinehart JD, Inskeep EK, Flores JA. Effects of endothelin receptor type-A and type-B antagonists on prostaglandin F2alpha-induced luteolysis of the sheep corpus luteum. Biol Reprod 2008; 78:688-696.
27. Hinckley ST, Milvae RA. Endothelin-1 mediates prostaglandin F(2alpha)- induced luteal regression in the ewe. Biol Reprod 2001; 64:1619-1623.
28. Shirasuna K, Sasahara K, Matsui M, Shimizu T, Miyamoto A. Prostaglandin F2alpha differentially affects mRNA expression relating to angiogenesis, vasoactivation and prostaglandins in the early and mid corpus luteum in the cow. J Reprod Dev 2010; 56:428-436.
29. Miyamoto A, Shirasuna K, Shimizu T, Bollwein H, Schams D. Regulation of corpus luteum development and maintenance: specific roles of angiogenesis and action of prostaglandin F2alpha. Soc Reprod Fertil Suppl 2010; 67:289-304.
30. Neuvians TP, Berisha B, Schams D. Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum. Mol Reprod Dev 2004; 67:389-395.
31. Berisha B, Sinowatz F, Schams D. Expression and localization of fibroblast growth factor (FGF) family members during the final growth of bovine ovarian follicles. Mol Reprod Dev 2004; 67:162-171.
32. Robinson RS, Woad KJ, Hammond AJ, Laird M, Hunter MG, Mann GE. Angiogenesis and vascular function in the ovary. Reproduction 2009;138:869-881.
33. Yamashita H, Kamada D, Shirasuna K, Matsui M, Shimizu T, Kida K, Berisha B, Schams D, Miyamoto A. Effect of local neutralization of basic fibroblast growth factor or vascular endothelial growth factor by a specific antibody on the development of the corpus luteum in the cow. Mol Reprod Dev 2008; 75:1449-1456.
34. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. Expression and localisation of vascular endothelial growth factor and basic fibroblast growth factor during the final growth of bovine ovarian follicles. J Endocrinol 2000; 167:371-382.
35. Robinson RS, Nicklin LT, Hammond AJ, Schams D, Hunter MG, Mann GE. Fibroblast growth factor 2 is more dynamic than vascular endothelial growth factor A during the follicle-luteal transition in the cow. Biol Reprod 2007; 77:28-36.
36. Woad KJ, Hammond AJ, Hunter M, Mann GE, Hunter MG, Robinson RS. FGF2 is crucial for the development of bovine luteal endothelial networks in vitro. Reproduction 2009; 138:581-588.
37. Leali D, Alessi P, Coltrini D, Rusnati M, Zetta L, Presta M. Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3- derived synthetic peptides. Curr Pharm Des 2009; 15:3577-3589.
38. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007; 100:158-173.
39. Podlovni H, Ovadia O, Kisliouk T, Klipper E, Zhou QY, Friedman A, Alfaidy N, Meidan R. Differential expression of prokineticin receptors by endothelial cells derived from different vascular beds: a physiological basis for distinct endothelial function. Cell Physiol Biochem 2006;18:315-326.
40. Langenkamp E, Molema G. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res 2009; 335:205-222.
41. Margheri F, Serrati S, Lapucci A, Anastasia C, Giusti B, Pucci M, Torre E, Bianchini F, Calorini L, Albini A, Ventura A, Fibbi G, et al. Systemic sclerosis-endothelial cell antiangiogenic pentraxin 3 and matrix metalloprotease 12 control human breast cancer tumor vascularization and development in mice. Neoplasia 2009; 11:1106-1115.
42. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of the soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007;11:723-738.
43. Camozzi M, Rusnati M, Bugatti A, Bottazzi B, Mantovani A, Bastone A, Inforzato A, Vincenti S, Bracci L, Mastroianni D, Presta M. Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3. J Biol Chem 2006; 281:22605-22613.
44. Pate JL, Toyokawa K, Walusimbi S, Brzezicka E. The interface of the immune and reproductive systems in the ovary: lessons learned from the corpus luteum of domestic animal models. Am J Reprod Immunol 2010;64:275-286.
45. Margheri F, Serrati S, Lapucci A, Chilla A, Bazzichi L, Bombardieri S, Kahaleh B, Calorini L, Bianchini F, Fibbi G, Del Rosso M. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12. Arthritis Rheum 2010; 62:2488-2498.
46. Inforzato A, Baldock C, Jowitt TA, Holmes DF, Lindstedt R, Marcellini M, Rivieccio V, Briggs DC, Kadler KE, Verdoliva A, Bottazzi B, Mantovani A, et al. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2. J Biol Chem 2010; 285:17681-17692.
47. Lawler J. The functions of thrombospondin-1 and_2. Curr Opin Cell Biol 2000; 12:634-640.
48. Mirochnik Y, Kwiatek A, Volpert OV. Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments. Curr Drug Targets 2008; 9:851-862.
49. Iruela-Arispe ML, Luque A, Lee N. Thrombospondin modules and angiogenesis. Int J Biochem Cell Biol 2004; 36:1070-1078.
50. Campbell NE, Greenaway J, Henkin J, Moorehead RA, Petrik J. The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer. Neoplasia 2010; 12:275-283.
51. Garside SA, Henkin J, Morris KD, Norvell SM, Thomas FH, Fraser HM. A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo. Endocrinology 2010; 151:5905-5915.
52. Bertolino P, Deckers M, Lebrin F, ten Dijke P. Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest 2005; 128:585S-590S.
53. Maroni D, Davis JS. TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum. J Cell Sci 2011;124:2501-2510.
54. Garside SA, Harlow CR, Hillier SG, Fraser HM, Thomas FH. Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay. Endocrinology 2010; 151:1280-1289.
55. Zhang B, Tsang PC, Pate JL, Moses MAA. Role for cysteine-rich CYR61 in the angiogenic switch during the estrous cycle in cows: regulation by prostaglandin F2alpha. Biol Reprod 2011; 85:261-268.
56. Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM. Regulation and action of angiogenic factors in the primate ovary. Arch Med Res 2001; 32:567-575.
57. Fraser HM, Duncan WC. Vascular morphogenesis in the primate ovary. Angiogenesis 2005; 8:101-116.
58. Wiltbank MC, Dysko RC, Gallagher KP, Keyes PL. Relationship between blood flow and steroidogenesis in the rabbit corpus luteum. J Reprod Fertil 1988; 84:513-520.
59. Grasselli F, Basini G, Bussolati S, Tamanini C. Effects of VEGF and bFGF on proliferation and production of steroids and nitric oxide in porcine granulosa cells. Reprod Domest Anim 2002; 37:362-368.
60. Schams D, Amselgruber W, Einspanier R, Sinowatz F, Gospodarowicz D. Localization and tissue concentration of basic fibroblast growth factor in the bovine corpus luteum. Endocrine 1994; 2:907-912.